Clear Labs is a biotechnology firm that utilizes a genomics system to enhance diagnostic accuracy in clinical and application sectors. The company addresses the complexity of traditional diagnostic processes by providing streamlined genomic analysis, enabling faster and more reliable results.
Funding
$156.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+5Founders
Product
Problem
Traditional diagnostic processes often involve complex and time-consuming procedures, leading to delays in obtaining reliable results in clinical and food safety sectors. Existing methods may lack the sensitivity and specificity needed for accurate pathogen identification and characterization, hindering effective disease surveillance and prevention efforts.
Solution
Clear Labs provides genomics solutions that automate next-generation sequencing (NGS) for clinical diagnostics and food safety. The Clear Dx™ platform offers fully automated sequencing for microbial and viral pathogens, reducing hands-on time and accelerating turnaround times. For food safety, Clear Safety™ leverages NGS to enable deep molecular characterization of pathogens like Listeria and Salmonella, offering insights for environmental monitoring and quality assurance. By integrating automated workflows with intuitive software and bioinformatics pipelines, Clear Labs delivers actionable insights for pathogen surveillance and outbreak management.
Target Audience
The primary customers include clinical and public health labs seeking advanced diagnostic tools for infectious disease surveillance, as well as food manufacturers and testing laboratories focused on ensuring food safety and quality.
Features
- Fully automated next-generation sequencing platform for clinical and public health labs
- Clear Dx™ enables rapid, high-throughput characterization of microbial and viral pathogens
- Clear Safety™ offers Listeria and Salmonella testing with deep molecular characterization
- Automated workflows reduce hands-on labor and minimize potential for errors
- Streamlined data management with integrated bioinformatics and intuitive software interface
- Environmental mapping capabilities for visualizing contamination incidents and tracking pathogen flow
- Both Clear Dx and Clear Safety platforms provide open API integration as well as sequencing files and quality metrics for each sample after analysis